Exelon is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Rivastigmine Tartrate.
Product ID | 0078-0325_cb8c7caf-a61a-48a7-933d-4720ee22cdbc |
NDC | 0078-0325 |
Product Type | Human Prescription Drug |
Proprietary Name | Exelon |
Generic Name | Rivastigmine Tartrate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2000-04-30 |
Marketing Category | NDA / NDA |
Application Number | NDA020823 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | RIVASTIGMINE TARTRATE |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2000-04-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020823 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-04-13 |
Marketing Category | NDA |
Application Number | NDA020823 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2000-04-30 |
Marketing End Date | 2012-08-31 |
Marketing Category | NDA |
Application Number | NDA020823 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2000-04-30 |
Marketing Category | NDA |
Application Number | NDA020823 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2000-04-30 |
Marketing End Date | 2017-01-31 |
Marketing Category | NDA |
Application Number | NDA020823 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2000-04-30 |
Ingredient | Strength |
---|---|
RIVASTIGMINE TARTRATE | 4.5 mg/1 |
SPL SET ID: | f1e28b44-3897-4788-9659-f5d6bce4d91e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0323 | Exelon | rivastigmine tartrate |
0078-0324 | Exelon | rivastigmine tartrate |
0078-0325 | Exelon | rivastigmine tartrate |
0078-0326 | Exelon | rivastigmine tartrate |
0078-0501 | Exelon | rivastigmine |
0078-0502 | Exelon | rivastigmine |
0078-0503 | Exelon | rivastigmine |
21695-357 | Exelon | rivastigmine |
0591-3208 | Rivastigmine Tartrate | Rivastigmine Tartrate |
0591-3209 | Rivastigmine Tartrate | Rivastigmine Tartrate |
0591-3210 | Rivastigmine Tartrate | Rivastigmine Tartrate |
0591-3211 | Rivastigmine Tartrate | Rivastigmine Tartrate |
0781-2614 | Rivastigmine Tartrate | rivastigmine tartrate |
0781-2615 | Rivastigmine Tartrate | rivastigmine tartrate |
0781-2616 | Rivastigmine Tartrate | rivastigmine tartrate |
0781-2617 | Rivastigmine Tartrate | rivastigmine tartrate |
0904-6587 | Rivastigmine Tartrate | Rivastigmine Tartrate |
0904-7107 | Rivastigmine Tartrate | Rivastigmine Tartrate |
27241-090 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE |
27241-091 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE |
27241-092 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE |
27241-093 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE |
33342-089 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EXELON 97977525 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
EXELON 97977523 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
EXELON 97110038 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
EXELON 97110036 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
EXELON 86776336 5508909 Live/Registered |
Exelon Corporation 2015-10-02 |
EXELON 86776333 5508908 Live/Registered |
Exelon Corporation 2015-10-02 |
EXELON 86302338 4671120 Live/Registered |
Exelon Corporation 2014-06-06 |
EXELON 85982666 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |
EXELON 85982665 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |
EXELON 85980324 4445212 Live/Registered |
Exelon Corporation 2012-05-24 |
EXELON 85980323 4445211 Live/Registered |
Exelon Corporation 2012-05-24 |
EXELON 85634507 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |